Chemotherapy is one of the most widely used treatments for cancer. For many patients, it plays a vital role in improving survival rates, controlling disease, and preventing recurrence. However, chemotherapy is also a powerful form of treatment that carries significant risks. When it is prescribed, administered, or monitored incorrectly, the consequences for patients can be serious.
Chemotherapy negligence occurs when medical professionals fail to provide treatment in accordance with accepted medical standards, and that failure results in avoidable harm.
To explore this topic in more detail, this guide examines:
- How chemotherapy treatment is normally managed
- Common examples of chemotherapy negligence
- When errors may give rise to a clinical negligence claim
- Frequently asked questions
How Chemotherapy Treatment Is Managed
Chemotherapy treatment is usually planned and delivered through a multidisciplinary cancer care team. This team often includes oncologists, specialist nurses, pharmacists, radiologists, and other healthcare professionals who work together to determine the most appropriate treatment plan.
Before chemotherapy begins, doctors typically assess several key factors, including:
- The type and stage of cancer
- The patient’s overall health
- The patient’s weight or body surface area, blood results, and kidney and liver function
- The likely benefits and risks of the proposed treatment
- Whether the patient is fit to proceed with treatment on the planned date
Treatment plans are generally based on established national or international guidelines. These guidelines set out recommended drugs, dosage levels, and treatment duration for different types of cancer. In practice, treatment should also comply with local hospital protocols, prescribing safeguards, and pharmacy verification processes.
Chemotherapy is commonly administered in cycles. Each cycle consists of a period of treatment followed by a recovery period to allow the body to recover from the effects of the medication.
Because chemotherapy drugs affect rapidly dividing cells throughout the body, they can cause significant side effects. These may include fatigue, nausea, increased risk of infection, hair loss, and damage to organs such as the heart or kidneys. Some patients may also develop neuropathy, severe mucositis, neutropenic sepsis, or complications caused by the chemotherapy leaking into surrounding tissue (known as extravasation). Careful monitoring is therefore essential to ensure that the treatment remains justified and that the benefits outweigh the risks.
Patients should also be given clear advice about material risks, expected side effects, warning signs requiring urgent medical attention, and the alternatives to the proposed treatment. From a legal perspective, failures in the consent process may be relevant as well as errors in prescribing or administration.
Common Examples of Chemotherapy Negligence
Chemotherapy negligence can arise at several stages of treatment, from diagnosis and planning through to prescribing, administration, monitoring, and follow-up.
Unnecessary or Prolonged Chemotherapy
One of the most serious forms of chemotherapy negligence involves patients receiving treatment that was not medically required or continuing treatment for significantly longer than clinical guidelines recommend.
For example, a patient may be kept on a chemotherapy regime after the recommended course has ended, despite there being no clear clinical justification for continuing treatment. In those circumstances, the patient may be exposed to avoidable toxicity, repeated hospital attendances, and unnecessary side effects without any corresponding medical benefit. Cases of this kind can raise serious questions about whether treatment remained supported by recognised clinical guidance.
A widely reported example involved Samantha Smith, a mother of three who underwent more than six years of chemotherapy treatment that later appeared to be unnecessary. Samantha was diagnosed with a brain tumour in 2014 and received surgery, followed by radiotherapy and chemotherapy under the care of University Hospitals Coventry and Warwickshire NHS Trust.
Clinical guidance typically recommends a limited course of the chemotherapy drug involved, and yet Samantha remained on the medication for approximately six and a half years. The treatment only stopped after her consultant oncologist retired and her case was reviewed.
An internal review later acknowledged that the prolonged treatment was not supported by national guidelines or scientific evidence. The NHS trust apologised for the excessive treatment and confirmed that measures had been introduced to prevent similar cases in the future.
During those years, Samantha experienced significant side effects including fatigue, infections, and various other health complications that affected her ability to work and carry out normal daily activities. She has since instructed solicitors to investigate whether the extended course of chemotherapy amounted to clinical negligence.
Cases such as this illustrate how prolonged or unnecessary chemotherapy can have profound physical and emotional consequences for patients.
In some of the most severe claims, patients may even be treated for cancer that was later found not to be present at all, resulting in avoidable chemotherapy after an initial misdiagnosis of cancer. This is exactly what happened in a well-documented case involving a woman named Sarah Boyle.
Additional resource: A Guide to Cancer Misdiagnosis
Incorrect Chemotherapy Dosage
Chemotherapy drugs must be carefully calculated according to the patient’s body size, kidney function, and overall health. Administering too high a dose can lead to severe toxicity and life-threatening complications.
Conversely, prescribing too low a dose may make the treatment ineffective, potentially allowing cancer to progress. Dosage errors may occur because of miscalculation, failure to adjust treatment after blood test results, inaccurate recording of height or weight, or failures in prescribing and pharmacy checks.
Failure to Monitor Treatment
Patients receiving chemotherapy require regular monitoring to ensure the treatment remains safe and effective. Blood tests are commonly used to assess how the body is responding to the medication and to detect complications, such as infection risk or organ damage.
If healthcare professionals fail to review these results or adjust treatment appropriately, patients may continue receiving chemotherapy even when it is no longer safe. In some cases, failure to recognise signs of neutropenic sepsis or serious toxicity can amount to a medical emergency with very serious consequences.
This type of failure to monitor chemotherapy is a common feature in oncology negligence claims, particularly where abnormal blood results, deteriorating symptoms, or signs of infection were not acted on promptly.
Delayed Chemotherapy Treatment
In some cases, chemotherapy may be delayed due to administrative failures, poor communication between departments, or delays in reviewing test results. These delays can affect the effectiveness of cancer treatment and may allow the disease to progress further than it otherwise would have.
Learn more about delayed treatment claims.
Administration Errors
Chemotherapy may also be administered negligently. Examples include giving the wrong drug, using the wrong route of administration, administering treatment to the wrong patient, or failing to respond appropriately when serious side effects arise during treatment. Because chemotherapy drugs are high-risk medications, hospitals are expected to have strict checking systems in place.
Failure in Consent and Patient Information
Patients should be told about the material risks of chemotherapy, any reasonable alternative treatments, and the likely consequences of declining treatment. If a patient undergoes chemotherapy without being properly informed of material risks, and would have made a different decision had appropriate information been given, this may also give rise to a clinical negligence claim.
When Chemotherapy Errors May Qualify as Negligence
Not every complication during chemotherapy treatment is the result of negligence. Cancer treatment can be complex, and even appropriate treatment may involve unavoidable risks.
However, a clinical negligence claim may arise when the care provided falls below the standard expected of a reasonably competent medical professional and, on the balance of probabilities, that failure causes harm.
In legal terms, four key elements generally need to be established.
1. Duty of Care
Healthcare professionals responsible for a patient’s treatment owe a duty of care to provide treatment that meets accepted medical standards.
2. Breach of Duty
A breach occurs when the care provided falls below the standard expected of competent practitioners. As mentioned, this might involve prescribing inappropriate treatment or failing to follow clinical guidelines, failing to carry out adequate checks before treatment, failing to monitor known risks, or failing to obtain proper informed consent, for instance.
3. Causation
It must also be demonstrated that the negligent treatment directly caused harm. For example, unnecessary chemotherapy may cause avoidable illness or delayed treatment may allow cancer to progress.
4. Damage
Finally, the patient must have suffered measurable harm, such as physical injury, psychological distress, financial loss, or the need for further treatment.
Independent medical experts are usually required to review the patient’s medical records and provide opinions on whether appropriate care was provided. In chemotherapy claims, expert evidence is often needed from oncology specialists, and in some cases from pharmacy, nursing, or other relevant disciplines.
Frequently Asked Questions About Chemotherapy Negligence Claims
How long do I have to bring a chemotherapy negligence claim?
In England and Wales, a clinical negligence claim must generally be issued within three years of the date of the negligent treatment, or three years from the date when the patient first knew, or could reasonably have known, that negligent treatment may have caused harm. Different rules can apply for children, protected parties, and fatal medical negligence.
Who can bring a chemotherapy negligence claim?
Usually, the patient can bring the claim. If the patient is a child, a litigation friend can act on the child’s behalf. If the patient lacks capacity, a litigation friend may also conduct proceedings for them. In some circumstances, the estate or dependants of a deceased patient may be able to bring a claim arising from negligent cancer treatment.
What records are usually needed to investigate chemotherapy errors?
The key records often include oncology notes, consent forms, chemotherapy prescription charts, pharmacy records, blood test results, scan reports, MDT records, hospital correspondence, and any records relating to complications, admissions, or follow-up care. These documents are often central to assessing whether there has been chemotherapy negligence, oncology negligence, or a failure to monitor chemotherapy safely.
Do I need expert evidence to bring a claim?
In most cases, yes. Chemotherapy negligence claims usually require independent expert evidence to address breach of duty and causation. Depending on the issues involved, this may include evidence from oncology, pharmacy, nursing, or other relevant specialties.
What Compensation May Be Available?
If a chemotherapy negligence claim is successful, compensation may be awarded for both the physical and financial impact of the negligent treatment.
Compensation typically includes general damages, which reflect pain, suffering, and loss of quality of life, and special damages, which cover financial losses such as loss of earnings, medical expenses, rehabilitation costs, and care requirements.
In serious cases, compensation may also include funding for future treatment and long-term support.
Depending on the circumstances, a claim may also include travel costs, the value of care provided by family members, counselling or psychological treatment, and future loss of earnings or pension loss.
Making a Chemotherapy Negligence Claim
If you suffered harm because chemotherapy treatment was administered incorrectly or unnecessarily, it may be possible to investigate whether medical negligence occurred.
Specialist clinical negligence solicitors can review your medical records, obtain independent expert opinions, and assess whether the treatment you received met acceptable medical standards. This will usually involve considering what treatment should have been provided, whether the care fell below a reasonable standard, and whether that failing caused avoidable injury or loss.
To discuss a potential claim, contact our team of specialist solicitors.